A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4
Objective. To evaluate the short-duration hyperbaric oxygen therapy (HBOT) can improve HbA1c levels, leukocyte count, and serum creatinine levels in patients with diabetic foot ulcer (DFU) Wagner 3-4. Methods. Blood samples from all DFU patients at Sanglah General Hospital, Denpasar, were taken for...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2018/6425857 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850166671481765888 |
|---|---|
| author | Hendry Irawan I. Nyoman Semadi I. Gde Raka Widiana |
| author_facet | Hendry Irawan I. Nyoman Semadi I. Gde Raka Widiana |
| author_sort | Hendry Irawan |
| collection | DOAJ |
| description | Objective. To evaluate the short-duration hyperbaric oxygen therapy (HBOT) can improve HbA1c levels, leukocyte count, and serum creatinine levels in patients with diabetic foot ulcer (DFU) Wagner 3-4. Methods. Blood samples from all DFU patients at Sanglah General Hospital, Denpasar, were taken for HbA1c, leukocyte, and serum creatinine test before debridement procedure, and the patients were then grouped into either standard therapy or standard therapy with HBOT for 10 sessions (combination therapy). At the end of therapy, all blood tests were resumed. Results. Each group consisted of 15 patients. Results of laboratory analysis before and after treatment were significant regarding decrease of HbA1c levels in standard therapy (10.98 ± 2.37 % to 9.70 ± 2.46 %; p = 0.006), HbA1c levels in combination therapy (9.42 ± 1.96 % to 7.07 ± 1.16 %; p < 0.001), and leukocyte count in combination therapy (13.97 ± 6.24 x 103 cells/μL to 8.84 ± 2.88 x 103 cells/μL; p = 0.009). The HbA1c levels at the end of therapy were significantly different between groups (p = 0.001). Serum creatinine level was decreased only in combination therapy but it was not significant. The effect size of all variables was larger in the combination therapy, but it was not significant (p > 0.05). Conclusion. The use of short-duration HBOT on DFU reduces HbA1c levels, leukocyte count, and serum creatinine levels better than standard therapy alone. This protocol would save time and effort in future HBOT implementation. This trial is registered with ClinicalTrials.gov Identifier: NCT03615755. |
| format | Article |
| id | doaj-art-e34b2ddc9fb24560b34485f6bbf04ea9 |
| institution | OA Journals |
| issn | 2356-6140 1537-744X |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-e34b2ddc9fb24560b34485f6bbf04ea92025-08-20T02:21:24ZengWileyThe Scientific World Journal2356-61401537-744X2018-01-01201810.1155/2018/64258576425857A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4Hendry Irawan0I. Nyoman Semadi1I. Gde Raka Widiana2Surgery Department, Faculty of Medicine, Udayana University, Sanglah General Hospital, Denpasar, IndonesiaThorax and Cardiovascular Surgery Division, Surgery Department, Faculty of Medicine, Udayana University, Sanglah General Hospital, Denpasar, IndonesiaNephrology and Hypertension Division, Internal Medicine Department, Faculty of Medicine, Udayana University, Sanglah General Hospital, Denpasar, IndonesiaObjective. To evaluate the short-duration hyperbaric oxygen therapy (HBOT) can improve HbA1c levels, leukocyte count, and serum creatinine levels in patients with diabetic foot ulcer (DFU) Wagner 3-4. Methods. Blood samples from all DFU patients at Sanglah General Hospital, Denpasar, were taken for HbA1c, leukocyte, and serum creatinine test before debridement procedure, and the patients were then grouped into either standard therapy or standard therapy with HBOT for 10 sessions (combination therapy). At the end of therapy, all blood tests were resumed. Results. Each group consisted of 15 patients. Results of laboratory analysis before and after treatment were significant regarding decrease of HbA1c levels in standard therapy (10.98 ± 2.37 % to 9.70 ± 2.46 %; p = 0.006), HbA1c levels in combination therapy (9.42 ± 1.96 % to 7.07 ± 1.16 %; p < 0.001), and leukocyte count in combination therapy (13.97 ± 6.24 x 103 cells/μL to 8.84 ± 2.88 x 103 cells/μL; p = 0.009). The HbA1c levels at the end of therapy were significantly different between groups (p = 0.001). Serum creatinine level was decreased only in combination therapy but it was not significant. The effect size of all variables was larger in the combination therapy, but it was not significant (p > 0.05). Conclusion. The use of short-duration HBOT on DFU reduces HbA1c levels, leukocyte count, and serum creatinine levels better than standard therapy alone. This protocol would save time and effort in future HBOT implementation. This trial is registered with ClinicalTrials.gov Identifier: NCT03615755.http://dx.doi.org/10.1155/2018/6425857 |
| spellingShingle | Hendry Irawan I. Nyoman Semadi I. Gde Raka Widiana A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4 The Scientific World Journal |
| title | A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4 |
| title_full | A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4 |
| title_fullStr | A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4 |
| title_full_unstemmed | A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4 |
| title_short | A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4 |
| title_sort | pilot study of short duration hyperbaric oxygen therapy to improve hba1c leukocyte and serum creatinine in patients with diabetic foot ulcer wagner 3 4 |
| url | http://dx.doi.org/10.1155/2018/6425857 |
| work_keys_str_mv | AT hendryirawan apilotstudyofshortdurationhyperbaricoxygentherapytoimprovehba1cleukocyteandserumcreatinineinpatientswithdiabeticfootulcerwagner34 AT inyomansemadi apilotstudyofshortdurationhyperbaricoxygentherapytoimprovehba1cleukocyteandserumcreatinineinpatientswithdiabeticfootulcerwagner34 AT igderakawidiana apilotstudyofshortdurationhyperbaricoxygentherapytoimprovehba1cleukocyteandserumcreatinineinpatientswithdiabeticfootulcerwagner34 AT hendryirawan pilotstudyofshortdurationhyperbaricoxygentherapytoimprovehba1cleukocyteandserumcreatinineinpatientswithdiabeticfootulcerwagner34 AT inyomansemadi pilotstudyofshortdurationhyperbaricoxygentherapytoimprovehba1cleukocyteandserumcreatinineinpatientswithdiabeticfootulcerwagner34 AT igderakawidiana pilotstudyofshortdurationhyperbaricoxygentherapytoimprovehba1cleukocyteandserumcreatinineinpatientswithdiabeticfootulcerwagner34 |